These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension. Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008 [TBL] [Abstract][Full Text] [Related]
32. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship. Garg N; Sharma MK; Sinha N Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417 [TBL] [Abstract][Full Text] [Related]
33. Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial. Vizza CD; Jansa P; Teal S; Dombi T; Zhou D BMC Cardiovasc Disord; 2017 Sep; 17(1):239. PubMed ID: 28874133 [TBL] [Abstract][Full Text] [Related]
34. Comparative Safety of Drugs Targeting the Nitric Oxide Pathway in Pulmonary Hypertension: A Mixed Approach Combining a Meta-Analysis of Clinical Trials and a Disproportionality Analysis From the World Health Organization Pharmacovigilance Database. Khouri C; Lepelley M; Roustit M; Montastruc F; Humbert M; Cracowski JL Chest; 2018 Jul; 154(1):136-147. PubMed ID: 29275134 [TBL] [Abstract][Full Text] [Related]
35. Safety, tolerability, and efficacy of overnight switching from sildenafil to tadalafil in patients with pulmonary arterial hypertension. Shapiro S; Traiger G; Hill W; Zhang L; Doran AK Cardiovasc Ther; 2013 Oct; 31(5):274-9. PubMed ID: 23841794 [TBL] [Abstract][Full Text] [Related]
36. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618 [TBL] [Abstract][Full Text] [Related]
37. Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding. Rai N; Veeroju S; Schymura Y; Janssen W; Wietelmann A; Kojonazarov B; Weissmann N; Stasch JP; Ghofrani HA; Seeger W; Schermuly RT; Novoyatleva T Biomed Res Int; 2018; 2018():3293584. PubMed ID: 29511676 [TBL] [Abstract][Full Text] [Related]
38. Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation. Brun H; Holmstrøm H; Thaulow E; Damås JK; Yndestad A; Aukrust P; Ueland T Congenit Heart Dis; 2009; 4(3):153-9. PubMed ID: 19489942 [TBL] [Abstract][Full Text] [Related]
39. Novel therapeutic approaches in pulmonary arterial hypertension: focus on tadalafil. Levin YD; White RJ Drugs Today (Barc); 2011 Feb; 47(2):145-56. PubMed ID: 21431102 [TBL] [Abstract][Full Text] [Related]
40. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology. D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]